Figure 1.
Histogram of serum concentrations of lipopolysaccharide-binding protein (LBP) in the study population.
Figure 2.
Serum concentrations of lipopolysaccharide-binding protein (LBP) in the different age strata.
Horizontal lines represent median values, boxes represent the interquartile range, whiskers represent the range, and dots represent extreme values (higher than the 75th percentile plus 1.5 times the interquartile range). The P-values (top of the figure) reflect comparisons to the group of 18–30 year-old (Mann-Whitney test). NS, not significant (P>0.05); *, P<0.005.
Figure 3.
Serum concentrations of lipopolysaccharide-binding protein (LBP) according to age strata and body mass index (BMI).
Horizontal lines represent median values, boxes represent the interquartile range, whiskers represent the range, and dots represent extreme values (higher than the 75th percentile plus 1.5 times the interquartile range). P-values we obtained with the Jonkheere-Terpstra test for trend.
Figure 4.
Scatterplot of individual concentrations of lipopolysaccharide-binding protein (LBP) and HDL-cholesterol.
Correlation coefficient was obtained with the Spearman’s rank test.
Table 1.
Serum concentrations of lipopolysaccharide-binding protein (LBP) and soluble CD14 (sCD14) in relation to demographic variables, lifestyle factors, and metabolic abnormalities.
Table 2.
Multivariate analysis of factors associated with serum lipopolysaccharide-binding protein (LBP) concentrations: demographic factors, lifestyle factors and body mass.
Table 3.
Multivariate analysis of factors associated with serum lipopolysaccharide-binding protein (LBP) concentrations: metabolic syndrome components.
Table 4.
Serum concentrations of lipopolysaccharide-binding protein (LBP) and soluble CD14 (sCD14) in relation to common single nucleotide polymorphisms (SNPs) in the LBP, CD14, and TLR4 genes.
Table 5.
Correlation between serum lipopolysaccharide-binding protein (LBP) concentrations and concentrations of proinflammatory cytokines and liver enzymes.